4683 related articles for article (PubMed ID: 16487444)
1. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
2. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
[TBL] [Abstract][Full Text] [Related]
3. Blood coagulation and fibrinolytic activity in hypothyroidism.
Erem C; Kavgaci H; Ersöz HO; Hacihasanoglu A; Ukinç K; Karti SS; Deger O; Telatari M
Int J Clin Pract; 2003 Mar; 57(2):78-81. PubMed ID: 12661786
[TBL] [Abstract][Full Text] [Related]
4. Blood coagulation and fibrinolysis in patients with hyperthyroidism.
Erem C; Ersoz HO; Karti SS; Ukinç K; Hacihasanoglu A; Değer O; Telatar M
J Endocrinol Invest; 2002 Apr; 25(4):345-50. PubMed ID: 12030606
[TBL] [Abstract][Full Text] [Related]
5. Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications.
Erem C; Hacihasanoğlu A; Celik S; Ovali E; Ersöz HO; Ukinç K; Deger O; Telatar M
Med Princ Pract; 2005; 14(1):22-30. PubMed ID: 15608477
[TBL] [Abstract][Full Text] [Related]
6. [Plasma haemostatic and fibrinolytic activities and their relationship to levels of serum lipids and apolipoproteins in endogenous hypertriglyceridemic patients].
Shen T; Bai H; Liu B; Liu Y; Zhang Z; Deng Z
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):405-8. PubMed ID: 12910674
[TBL] [Abstract][Full Text] [Related]
7. Blood coagulation and fibrinolysis in male patients with hypogonadotropic hypogonadism: plasma factor V and factor X activities increase in hypogonadotropic hypogonadism.
Erem C; Kocak M; Hacihasanoglu A; Yilmaz M
J Endocrinol Invest; 2008 Jun; 31(6):537-41. PubMed ID: 18591887
[TBL] [Abstract][Full Text] [Related]
8. Relation of habitual diet and cardiorespiratory fitness to blood coagulation and fibrinolytic factors.
Rankinen T; Rauramaa R; Väisänen S; Penttilä IM; Uusitupa M
Thromb Haemost; 1994 Feb; 71(2):180-3. PubMed ID: 8191395
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA
Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
[TBL] [Abstract][Full Text] [Related]
10. Well-being, health-related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease - a community-based study.
Bell RJ; Rivera-Woll L; Davison SL; Topliss DJ; Donath S; Davis SR
Clin Endocrinol (Oxf); 2007 Apr; 66(4):548-56. PubMed ID: 17371474
[TBL] [Abstract][Full Text] [Related]
11. Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly.
Sartorio A; Cattaneo M; Bucciarelli P; Bottasso B; Porretti S; Epaminonda P; Faglia G; Arosio M
Exp Clin Endocrinol Diabetes; 2000; 108(7):486-92. PubMed ID: 11083070
[TBL] [Abstract][Full Text] [Related]
12. Relationship between thyroid hormones and plasma D-dimer levels.
Chadarevian R; Bruckert E; Ankri A; Beucler I; Giral P; Turpin G
Thromb Haemost; 1998 Jan; 79(1):99-103. PubMed ID: 9459332
[TBL] [Abstract][Full Text] [Related]
13. Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients.
Yavuz DG; Yüksel M; Deyneli O; Ozen Y; Aydin H; Akalin S
Clin Endocrinol (Oxf); 2004 Oct; 61(4):515-21. PubMed ID: 15473886
[TBL] [Abstract][Full Text] [Related]
14. Improved endothelial function and lipid profile compensate for impaired hemostatic and inflammatory status in iatrogenic chronic subclinical hyperthyroidism of thyroid cancer patients on L-t4 therapy.
Gazdag A; Nagy EV; Burman KD; Paragh G; Jenei Z
Exp Clin Endocrinol Diabetes; 2010 Jun; 118(6):381-7. PubMed ID: 19658059
[TBL] [Abstract][Full Text] [Related]
15. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism.
Altinova AE; Törüner FB; Aktürk M; Bukan N; Cakir N; Ayvaz G; Arslan M
Clin Endocrinol (Oxf); 2006 Oct; 65(4):530-5. PubMed ID: 16984248
[TBL] [Abstract][Full Text] [Related]
17. Dyslipidemias and fibrinolysis.
Puccetti L; Bruni F; Pasqui AL; Pastorelli M; Bova G; Cercignani M; Palazzuoli A; Auteri A
Ital Heart J; 2002 Oct; 3(10):579-86. PubMed ID: 12478815
[TBL] [Abstract][Full Text] [Related]
18. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I
Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166
[TBL] [Abstract][Full Text] [Related]
19. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
20. Premature coronary artery disease in young (age <45) subjects: interactions of lipid profile, thrombophilic and haemostatic markers.
Pineda J; Marín F; Marco P; Roldán V; Valencia J; Ruiz-Nodar JM; Sogorb F; Lip GY
Int J Cardiol; 2009 Aug; 136(2):222-5. PubMed ID: 18625524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]